These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26773923)

  • 21. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct costs of opioid abuse in an insured population in the United States.
    White AG; Birnbaum HG; Mareva MN; Daher M; Vallow S; Schein J; Katz N
    J Manag Care Pharm; 2005; 11(6):469-79. PubMed ID: 15998164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
    Feldman SR; Zhao Y; Shi L; Tran MH
    J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Depression on Health and Medical Care Utilization and Expenses in US Adults With Migraine: A Retrospective Cross Sectional Study.
    Wu J; Davis-Ajami ML; Kevin Lu Z
    Headache; 2016 Jul; 56(7):1147-60. PubMed ID: 27350407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims.
    Suh DC; Sung J; Gause D; Raut M; Huang J; Choi IS
    J Manag Care Pharm; 2007; 13(9):778-89. PubMed ID: 18062729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of health care costs associated with depression and substance abuse in a national sample.
    Druss BG; Rosenheck RA
    Psychiatr Serv; 1999 Feb; 50(2):214-8. PubMed ID: 10030479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicaid managed care: how to target efforts to reduce costs.
    Charlson ME; Wells MT; Kanna B; Dunn V; Michelen W
    BMC Health Serv Res; 2014 Nov; 14():461. PubMed ID: 25395056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital costs associated with psychiatric comorbidities: a retrospective study.
    Wolff J; Heister T; Normann C; Kaier K
    BMC Health Serv Res; 2018 Jan; 18(1):67. PubMed ID: 29382387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study.
    Black J; Reaven NL; Funk SE; McGaughey K; Ohayon MM; Guilleminault C; Ruoff C
    Sleep Med; 2017 May; 33():13-18. PubMed ID: 28449892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016.
    Zaprutko T; Göder R; Kus K; Pałys W; Rybakowski F; Nowakowska E
    PLoS One; 2018; 13(6):e0198890. PubMed ID: 29902259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. German general practitioners' self-reported management of patients with chronic depression.
    Wolf F; Freytag A; Schulz S; Lehmann T; Schaffer S; Vollmar HC; Kühlein T; Gensichen J
    BMC Psychiatry; 2017 Dec; 17(1):401. PubMed ID: 29237425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of coordinated versus uncoordinated care in Germany: results of a routine data analysis in Bavaria.
    Schneider A; Donnachie E; Tauscher M; Gerlach R; Maier W; Mielck A; Linde K; Mehring M
    BMJ Open; 2016 Jun; 6(6):e011621. PubMed ID: 27288386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
    Centorrino F; Mark TL; Talamo A; Oh K; Chang J
    J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource use and costs associated with patients treated for depression in primary care.
    Sobocki P; Ekman M; Agren H; Krakau I; Runeson B; Mårtensson B; Jönsson B
    Eur J Health Econ; 2007 Mar; 8(1):67-76. PubMed ID: 17165073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
    Guo JJ; Keck PE; Li H; Patel NC
    Psychiatr Serv; 2007 Aug; 58(8):1073-8. PubMed ID: 17664518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011.
    Egede LE; Bishu KG; Walker RJ; Dismuke CE
    J Affect Disord; 2016 May; 195():119-26. PubMed ID: 26890289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.